A critical review of the use of R(2) in risk equalization research

对风险均衡研究中 R(2) 的应用进行批判性回顾

阅读:2

Abstract

Nearly all empirical studies that estimate the coefficients of a risk equalization formula present the value of the statistical measure R(2). The R(2)-value is often (implicitly) interpreted as a measure of the extent to which the risk equalization payments remove the regulation-induced predictable profits and losses on the insured, with a higher R(2)-value indicating a better performance. In many cases, however, we do not know whether a model with R(2) = 0.30 reduces the predictable profits and losses more than a model with R(2) = 0.20. In this paper we argue that in the context of risk equalization R(2) is hard to interpret as a measure of selection incentives, can lead to wrong and misleading conclusions when used as a measure of selection incentives, and is therefore not useful for measuring selection incentives. The same is true for related statistical measures such as the Mean Absolute Prediction Error (MAPE), Cumming's Prediction Measure (CPM) and the Payment System Fit (PSF). There are some exceptions where the R(2) can be useful. Our recommendation is to either present the R(2) with a clear, valid, and relevant interpretation or not to present the R(2). The same holds for the related statistical measures MAPE, CPM and PSF.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。